Symbol="KRTX"
AssetType="Common Stock"
Name="Karuna Therapeutics Inc"
Description="Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative drugs for people living with psychiatric and neurological conditions. The company is headquartered in Boston, Massachusetts."
CIK="1771917"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="33 ARCH STREET, SUITE 3110, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="6587722000"
EBITDA="-393024000"
PERatio="None"
PEGRatio="None"
BookValue="37.71"
DividendPerShare="0"
DividendYield="0"
EPS="-10.27"
RevenuePerShareTTM="0.173"
ProfitMargin="0"
OperatingMarginTTM="-65.59"
ReturnOnAssetsTTM="-0.259"
ReturnOnEquityTTM="-0.388"
RevenueTTM="6013000"
GrossProfitTTM="10637000"
DilutedEPSTTM="-10.27"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.857"
AnalystTargetPrice="275.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="162.38"
PriceToBookRatio="5.94"
EVToRevenue="138.07"
EVToEBITDA="-25.22"
Beta="1.0"
num_52WeekHigh="274.82"
num_52WeekLow="159.73"
num_50DayMovingAverage="207.66"
num_200DayMovingAverage="204.28"
SharesOutstanding="37444000"
DividendDate="None"
ExDividendDate="None"
symbol="KRTX"
open="176.46"
high="178.91"
low="174.09"
price="174.61"
volume="297626.00"
latest_trading_day="2023-08-22"
previous_close="174.89"
change="-0.28"
change_percent="-0.1601%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="42"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="58"
Volume_recent_avg="360082"
Change_recent_avg="0.11"
Delta_recent_avg="6.42"
Variance_recent_avg="3.21"
Change_ratio_recent_avg="0.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="58"
Aroon_momentum_negative="42"
image_negative_thumbnail_id_1="148"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0028.jpeg"
image_negative_thumbnail_id_2="155"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0021.jpeg"
image_neutral_thumbnail_id_1="521"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_neutral_thumbnail_id_2="552"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_positive_thumbnail_id_1="637"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_positive_thumbnail_id_2="660"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0048.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
